WH To Collaborate With Antibody Developers To Target COVID-19 Mutations

The U.S. government will collaborate with monoclonal antibody developers to target the potentially serious impacts a new strain of COVID-19 found in South Africa poses to the therapy’s efficacy, the White House COVID-19 Response Team announced Wednesday (Jan. 27). The same day, a handful of companies announced they have already begun to experiment with new antibody cocktails that could be effective in combating the new viral strains, and one company is already looking to get its antibody product authorized as...